| 产品名称 |
Recombinant SARS-CoV-2 NSP2 (C-6His) |
| 英文名称 |
NSP2 |
| 纯度 |
Greater than 95% as determined by reducing SDS-PAGE |
| 内毒素 |
Please contact with the lab for this information |
| 蛋白构建 |
Recombinant 2019-nCoV NSP2 is produced by our E.coli expression system and the target gene encoding Ala1-Gly638 is expressed with a 6His tag at the C-terminus. |
| Accession |
YP_009725298.1 |
| 表达宿主 |
E.coli |
| 种属 |
SARS-CoV-2 |
| 预测分子量 |
73.6 KDa |
| 制剂 |
Supplied as a 0.2 μm filtered solution of PBS, 10% Glycerol, pH 7.4. |
| 运输方式 |
The product is shipped on dry ice/polar packs.Upon receipt, store it immediately at the temperature listed below. |
| 稳定性&储存 |
Store at ≤-70°C, stable for 6 months after receipt.Store at ≤-70°C, stable for 3 months under sterile conditions after opening. Please minimize freeze-thaw cycles. |
| 复溶 |
| 分子别名 |
| SARS-CoV 2 nsp2; SARS-CoV 2 p65 homolog |
| 背景介绍 |
| The positive-stranded RNA genome of the coronaviruses is translated from ORF1 to yield polyproteins that are proteolytically processed into intermediate and mature nonstructural proteins (nsps). SARS-CoV 2 polyproteins incorporate 16 protein domains (nsps). The putative non-structural protein 2 (nsp2) of SARS-CoV plays an important role in viral transcription and replication, and is an attractive target for anti-SARS drug development. |
注意事项
本司产品仅用于科研，不用于临床诊断和治疗
